Cookie Settings

We use cookies to optimize our website. These include cookies that are necessary for the operation of the site, as well as those that are only used for anonymous statistic. You can decide for yourself which categories you want to allow. Further information can be found in our data privacy protection .


These cookies are necessary to run the core functionalities of this website and cannot be disabled.

Name Webedition CMS
Purpose This cookie is required by the CMS (Content Management System) Webedition for the system to function correctly. Typically, this cookie is deleted when the browser is closed.
Name econda
Purpose Session cookie emos_jcsid for the web analysis software econda. This runs in the “anonymized measurement” mode. There is no personal reference. As soon as the user leaves the site, tracking is ended and all data in the browser are automatically deleted.

These cookies help us understand how visitors interact with our website by collecting and analyzing information anonymously. Depending on the tool, one or more cookies are set by the provider.

Name econda
Purpose Statistics
External media

Content from external media platforms is blocked by default. If cookies from external media are accepted, access to this content no longer requires manual consent.

Name YouTube
Purpose Show YouTube content
Name Twitter
Purpose activate Twitter Feeds

Federal Health Minister Hermann Gröhe visits the German Cancer Research Center and the National Center for Tumor Diseases

No. 34 | 10/07/2014 | by Koh

This year, the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) celebrates its 50th anniversary, and the National Center for Tumor Diseases (NCT) Heidelberg celebrates its 10th anniversary. On the occasion of this joint anniversary, Federal Minister of Health Hermann Gröhe made a visit to both institutes in Heidelberg.

Dr. Karl Lamers, MdB, Prof. Dr. Otmar Wiestler, Vorstandsvorsitzender Deutsches Krebsforschungszentrum, Hermann Gröhe, Bundesminister für Gesundheit, Prof. Dr. Josef Puchta, Administrativ-kaufmännischer Vorstand Deutsches Krebsforschungszentrum /from left to right)
© Jutta Jung/DKFZ

“Cancer research is currently going through an exciting and vibrant phase,” said Professor Otmar Wiestler, Chairman of the Management Board and Scientific Director of the DKFZ, in welcoming the minister. “Never before has it been possible to translate so many research results into clinical applications so rapidly. A prerequisite to achieving enhancements for patients is the close collaboration of excellent cancer research and cancer medicine. To this end, we established the NCT 10 years ago as an institution with a model character for the whole of Germany; it is also setting new standards in the care of cancer patients.”

Dr. Susanne Weg-Remers, head of the DKFZ’s Cancer Information Service, explained why it is so important to provide neutral and independent information for people affected by cancer. Health Minister Hermann Gröhe said: “Supporting cancer patients and their families with quality information is an important goal of the National Cancer Plan. The Cancer Information Service was established to offer comprehensive patient-oriented information about all matters relating to cancer.”

Professor Olaf Witt briefed the minister about plans for a project called INFORM, which aims to open up a second avenue towards cures for children who suffer from recurrent cancer. Physicians and scientists participating in this project plan to search across Germany for a drug that precisely targets the tumor of each child with recurrent cancer. The basis for this effort is a comprehensive analysis of the changes in a tumor's genetic information at the time of the relapse.

Subsequently, the Federal Minister met with members of the board of directors of the National Center for Tumor Diseases (NCT) and with Professor Guido Adler, Chief Medical Director of the University Medical Center Heidelberg. With NCT directors Professor Christof von Kalle, Professor Dirk Jäger, Professor Cornelia Ulrich and Professor Wolfgang Wick, the Health Minister talked about the new chances that personalized cancer medicine is offering to patients. The NCT aims to offer individualized treatment for each of its cancer patients based on molecular analyses of the genomes of their individual tumors.

Concluding his visit, Gröhe resumed: “Thanks to the DKFZ and the NCT, Heidelberg has assumed a leading position worldwide in cancer research and cancer medicine. It is a good thing that this model is now being transferred to seven other sites in Germany within the German Cancer Consortium.”

With more than 3,000 employees, the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) is Germany’s largest biomedical research institute. DKFZ scientists identify cancer risk factors, investigate how cancer progresses and develop new cancer prevention strategies. They are also developing new methods to diagnose tumors more precisely and treat cancer patients more successfully. The DKFZ's Cancer Information Service (KID) provides patients, interested citizens and experts with individual answers to questions relating to cancer.

To transfer promising approaches from cancer research to the clinic and thus improve the prognosis of cancer patients, the DKFZ cooperates with excellent research institutions and university hospitals throughout Germany:

  • National Center for Tumor Diseases (NCT, 6 sites)
  • German Cancer Consortium (DKTK, 8 sites)
  • Hopp Children's Cancer Center (KiTZ) Heidelberg
  • Helmholtz Institute for Translational Oncology (HI-TRON Mainz) - A Helmholtz Institute of the DKFZ
  • DKFZ-Hector Cancer Institute at the University Medical Center Mannheim
  • National Cancer Prevention Center (jointly with German Cancer Aid)
The DKFZ is 90 percent financed by the Federal Ministry of Education and Research and 10 percent by the state of Baden-Württemberg. The DKFZ is a member of the Helmholtz Association of German Research Centers.


Subscribe to our RSS-Feed.

to top
powered by webEdition CMS